[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351271-105":59,"doc-detail-351271-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","enolase-1-a-paradigm-of-metabolic-enzyme-moonlighting-in-tumorigenesis-review","Enolase 1 - A paradigm of metabolic enzyme moonlighting in tumorigenesis - Review","","Enolase 1 (ENO1) is a key player in tumor development, functioning as a multifunctional oncogene across diverse cancers. Beyond glycolysis, ENO1 supports tumor progression through plasminogen receptor activity, nucleic acid binding, and signaling functions. Its activity, stability, and subcellular localization are tuned by multiple post-translational modifications, including phosphorylation, ubiquitination, acetylation, methylation, succinylation, and glycosylation. ENO1 also shows diagnostic and prognostic value and represents a promising therapeutic target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/enolase-1-a-paradigm-of-metabolic-enzyme-moonlighting-in-tumorigenesis-review/351271/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/enolase-1-a-paradigm-of-metabolic-enzyme-moonlighting-in-tumorigenesis-review/351271.png","ImageObject",300,407,{"name":92,"@type":93},"Rhys","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the biological role of ENO1 in tumorigenesis?","Question",{"text":112,"@type":113},"ENO1 acts as a multifunctional oncogene. In addition to glycolysis, it promotes tumor progression via plasminogen receptor activity, nucleic acid binding, and signaling functions.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is ENO1 regulated in cancer cells?",{"text":117,"@type":113},"ENO1 is regulated by a wide range of post-translational modifications, including phosphorylation, ubiquitination, acetylation, methylation, succinylation, and glycosylation, which affect its activity, stability, and localization.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is ENO1 considered a therapeutic target and what do preclinical data suggest?",{"text":121,"@type":113},"ENO1 shows diagnostic and prognostic relevance linked to malignancy and survival. Preclinical models indicate that approaches targeting ENO1 can inhibit tumor progression, supporting drug development aimed at this protein.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351271,1790907649,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},687207024643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","INTERNATIONAL JOURNAL OF ONCOLOGY 68: 56, 2026  \nEnolase 1: A paradigm of metabolic enzyme moonlighting in tumorigenesis (Review)  \nXIAOCHEN NI 1,2 , MINGSI ZHANG 1‑3 , KAIYUAN ZHANG 1,2 , CHUHANG WANG 1,2 , JIANING GUO 1,2 , WEI FAN 1,2 , LINFENG ZHENG 1,2,4 , TAO JIANG 1,2,5 and GUANGJI ZHANG 1,2,5  \n1School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China; 2Zhejiang Key Laboratory of Blood‑Stasis‑Toxin Syndrome, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053,  \nP.R. China; 3Jinhua Academy of Zhejiang Chinese Medicine University, Jinghua, Zhejiang 321015, P.R. China; 4 5  \nDepartment of Pathology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China; Traditional Chinese Medicine‘Preventing Disease’Wisdom Health Project Research Center of Zhejiang, Hangzhou, Zhejiang 310053, P.R. China  \nReceived November 21, 2025; Accepted February 6, 2026  \nDOI: 10.3892/ijo.2026.5869  \nAbstract. Enolase 1 (ENO1) plays a pivotal role in tumor development, recognized as a multifunctional oncogene across diverse cancers. Initially known for its central role in glycolysis, where it catalyzes the conversion of 2‑phosphoglyc‑ erate to phosphoenolpyruvate, the influence of ENO1 extends  \nCorrespondence to: Professor Guangji Zhang or Professor Tao Jiang, School of Basic Medical Sciences, Zhejiang Chinese Medical University, 548 Binwen Road, Binjiang, Hangzhou, Zhejiang 310053, P.R. China  \nE‑mail: [zgjtcm@zcmu.edu.cn](zgjtcm@zcmu.edu.cn)  \nE‑mail: [jttcm@zcmu.edu.cn](jttcm@zcmu.edu.cn)  \nAbbreviations: ENO1, enolase 1; PLG, plasminogen; MBP‑1, c‑myc promoter‑binding protein 1; HIF‑1α , hypoxia‑inducible factor 1‑alpha; c‑Myc, myc proto‑oncogene protein; YAP1, Yes‑associated protein 1; PD‑L1, programmed death‑ligand 1; PTM, post‑translational modification; m6A, N6‑methyladenosine; m6C, 5‑methylcytosine; NSUN2, NOP2/Sun RNA methyltransferase 2; YBX1, Y‑box binding protein 1; CCDC65, coiled‑coil domain containing 65; WTAP, Wilms tumor 1‑associating protein; GPS2, G protein pathway suppressor 2; RACK1, receptor for activated C kinase 1; PRMT6, protein arginine methyltransferase 6; SUMO, small ubiquitin‑like modifier; O‑GlcNAc, o‑linked β‑n‑acetylglucosamine; PRMT5, protein arginine methyltransferase 5; KAT2A, lysine acetyltransferase 2a; USP21, ubiquitin specific peptidase 21; CTLA‑4, cytotoxic T‑lymphocyte‑associated protein 4; FBXW7, f‑box/WD repeat‑containing protein 7; PEP, phosphoenolpyruvate; ROS, reactive oxygen species; AKT, protein kinase B; PI3K, phosphoinositide 3‑kinase; mTOR, mechanistic target of rapamycin; AMPK, AMP‑activated protein kinase; ERK, extracellular signal‑regulated kinase; EMT, epithelial‑mesenchymal transition; TME, tumor microenvironment; MAPK, mitogen‑activated protein kinase; CPT1A, carnitine palmitoyltransferase 1a; PTMs, post‑translational modifications; HRE, hypoxia response element  \nKey words: enolase 1, glycolysis, tumorigenesis, post‑translational modifications, moonlighting protein  \nfar beyond. Recent studies have unveiled its additional roles in promoting tumor progression through plasminogen receptor activity, nucleic acid binding activity and signaling functions. The function of ENO1 is intricately regulated by a wide array of post‑translational modifications, such as phosphorylation, ubiquitination, acetylation, methylation, succinylation and glycosylation . These modifications fine‑tune its enzymatic activity, stability and subcellular localization, thereby affecting tumor behavior. ENO1 holds significant diagnostic and prognostic value, with its expression levels closely linked to tumor malignancy and patient survival outcomes . In preclinical models, multiple therapeutic approaches targeting ENO1 have demonstrated tumor progression‑inhibiting effects. Consequently, drug development efforts centered on ENO1 are gaining momentum, with anticancer agents targeting this protein showing promising potential. As ENO1 emerges as a novel","cbCaildGSYxRFUVU","https://ap.wps.com/l/cbCaildGSYxRFUVU","pdf",3930900,16,"English","# Introduction\n## ENO1 as a multifunctional protein\n## ENO1 enzyme activity: primarily regulated by PTMs\n## ENO1 as a mediator of pro-tumor signaling\n## ENO1-regulated tumor immune microenvironment\n## Therapeutic approaches targeting ENO1\n## Diagnostic and prognostic value of ENO1 in cancer\n## Conclusions and outlook","[{\"question\":\"What is the biological role of ENO1 in tumorigenesis?\",\"answer\":\"ENO1 acts as a multifunctional oncogene. In addition to glycolysis, it promotes tumor progression via plasminogen receptor activity, nucleic acid binding, and signaling functions.\"},{\"question\":\"How is ENO1 regulated in cancer cells?\",\"answer\":\"ENO1 is regulated by a wide range of post-translational modifications, including phosphorylation, ubiquitination, acetylation, methylation, succinylation, and glycosylation, which affect its activity, stability, and localization.\"},{\"question\":\"Why is ENO1 considered a therapeutic target and what do preclinical data suggest?\",\"answer\":\"ENO1 shows diagnostic and prognostic relevance linked to malignancy and survival. Preclinical models indicate that approaches targeting ENO1 can inhibit tumor progression, supporting drug development aimed at this protein.\"}]","Enolase 1 - A paradigm of metabolic enzyme moonlighting in tumorigenesis - Review | PDF",1790093293,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7f87137e9db5108e735bbd8c0e547a20.webp",983,1357,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f22eb0450a205d6fa0d997e440b3307.webp",982,1356,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cc493414f7502a66fa79aeb96c66b3d7.webp",981,1354,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/57508a070e5b2cd4e3227d01ca4ce70b.webp",980,1353]